These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2673608)

  • 1. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics.
    Miller LG
    Clin Pharmacokinet; 1989 Aug; 17(2):90-108. PubMed ID: 2673608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarettes and drug therapy: pharmacokinetic and pharmacodynamic considerations.
    Miller LG
    Clin Pharm; 1990 Feb; 9(2):125-35. PubMed ID: 2407422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective.
    Desai HD; Seabolt J; Jann MW
    CNS Drugs; 2001; 15(6):469-94. PubMed ID: 11524025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions with tobacco smoking. An update.
    Zevin S; Benowitz NL
    Clin Pharmacokinet; 1999 Jun; 36(6):425-38. PubMed ID: 10427467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking and clinically significant drug interactions.
    Schein JR
    Ann Pharmacother; 1995 Nov; 29(11):1139-48. PubMed ID: 8573960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of the effects of cigarette smoking on drug disposition.
    Luczynska C; Wilson K
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):479-87. PubMed ID: 6366402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing cigarette, 1950-1995.
    Hoffmann D; Hoffmann I
    J Toxicol Environ Health; 1997 Mar; 50(4):307-64. PubMed ID: 9120872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs and Diseases Interacting with Cigarette Smoking in US Prescription Drug Labelling.
    Li H; Shi Q
    Clin Pharmacokinet; 2015 May; 54(5):493-501. PubMed ID: 25701380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the effects of smoking on codeine pharmacokinetics and bioavailability in normal human volunteers.
    Hull JH; Findlay JW; Rogers JF; Welch RM; Butz RF; Bustrack JA
    Drug Intell Clin Pharm; 1982 Nov; 16(11):849-54. PubMed ID: 7173046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco smoking and drugs: a clinically important interaction?
    D'Arcy PF
    Drug Intell Clin Pharm; 1984 Apr; 18(4):302-7. PubMed ID: 6370644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of exposure to selected cigarette smoke constituents in adult smokers and nonsmokers in a European, multicenter, observational study.
    Lindner D; Smith S; Leroy CM; Tricker AR
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1524-36. PubMed ID: 21613391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic drug interactions in anaesthetic practice.
    Wood M
    Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction between smoking and drugs].
    Kimelski R
    Wiad Lek; 1986 Jan; 39(1):31-4. PubMed ID: 3521099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of ammonia toxicity on the exposure, deposition, retention, and the bioavailability of nicotine during smoking.
    Seeman JI; Carchman RA
    Food Chem Toxicol; 2008 Jun; 46(6):1863-81. PubMed ID: 18450355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism.
    Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB
    Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of drug interactions with smoking in modern drug research].
    Laki S; Kalapos-Kovács B; Antal I; Klebovich I
    Acta Pharm Hung; 2013; 83(4):107-20. PubMed ID: 24575657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
    Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
    Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good relationship between saliva cotinine kinetics and plasma cotinine kinetics after smoking one cigarette.
    Yuki D; Kikuchi A; Miura N; Kakehi A; Onozawa M
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):240-5. PubMed ID: 23933006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The feasibility of measuring puffing behaviour in roll-your-own cigarette smokers.
    Shahab L; West R; McNeill A
    Tob Control; 2008 Sep; 17 Suppl 1():i17-23. PubMed ID: 18768455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke.
    Melikian AA; Djordjevic MV; Hosey J; Zhang J; Chen S; Zang E; Muscat J; Stellman SD
    Nicotine Tob Res; 2007 Mar; 9(3):377-87. PubMed ID: 17365769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.